We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Health (UHS) to Report Q2 Earnings: What to Expect
Read MoreHide Full Article
Universal Health Services, Inc. (UHS - Free Report) is set to report second-quarter 2020 results on Jul 27, after market close.
For the to-be-reported quarter, the Zacks Consensus Estimate for earnings is pegged at 53 cents per share, indicating an 80.8% plunge from the year-ago reported figure.
Let’s see how things are shaping up for this announcement.
In the quarter to be reported, the company’s performance is likely to have been dented by lower admissions. The volume of non-COVID patients is expected to have declined in the period.
The company’s segments, namely Acute Care and Behavioral Health, which have been contributing to the top line over the last several quarters, might affect results due to the coronavirus pandemic.
The consensus mark for net revenues at Acute Care and Behavioral Health suggests a respective 16.9% and 9.8% fall from the prior-year reported numbers.
The company is likely to have witnessed lower emergency room visits and elective or scheduled procedures due to government-imposed restrictions. The Zacks Consensus Estimate for total revenues stands at $2.3 billion, implying a 16.5% deterioration from the year-earlier reported figure.
The consensus estimate for average licensed beds at Behavorial Health segment suggests a 0.7% dip while the same for acute care (U.S. and Puerto Rico) indicates an increase of 1.3%.
At Behavorial Health Centers, the consensus mark for patient days hints at a slip of 0.9% due to contracting patient volumes. While the estimate for patient days for acute care (U.S. and Puerto Rico) indicates a 5.3% drop year over year.
Also, the company is expected to have incurred escalating expenses due to higher salaries, wages and benefits plus other operating expenses, which in turn, might have weighed on its margins.
What the Quantitative Model States
Our proven model predicts an earnings beat for Universal Health this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: Universal Health has an Earnings ESP of +29.21%. This is because the Most Accurate Estimate is pegged at 69 cents per share, higher than the Zacks Consensus Estimate of 53 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Universal Health Services, Inc. Price and EPS Surprise
Zacks Rank: Universal Health carries a Zacks Rank #3, which increases the predictive power of ESP.
Q1 Highlights and Surprise History
Universal Health’s first-quarter 2020 adjusted earnings of $1.73 per share missed the Zacks Consensus Estimate by 33.2%. Moreover, the bottom line deteriorated 29.4% year over year.
Results were impacted by a pre-tax unrealized loss of $4.3 million due to lower market value of shares of certain securities.
The company’s earnings managed to beat estimates in two of the trailing four quarters and missed the same in the remaining two. The average trailing four-quarter surprise is a negative 6.9%.
Stocks to Consider
Some stocks worth considering from the medical sector with the perfect mix of elements to surpass estimates in the next releases are as follows:
Centene Corporation (CNC - Free Report) has an Earnings ESP of +0.88% and a Zacks Rank of 3, currently. The company is scheduled to release second-quarter earnings on Jul 28.
Anthem, Inc. is slated to announce second-quarter earnings on Jul 29. The stock has an Earnings ESP of +3.73% and a Zacks Rank #2 at present.
Molina Healthcare, Inc. (MOH - Free Report) is set to report second-quarter earnings on Jul 30. The stock is currently a #2 Ranked player and has an Earnings ESP of +4.08%.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early. See Zacks' 3 Best Stocks to Play This Trend >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Universal Health (UHS) to Report Q2 Earnings: What to Expect
Universal Health Services, Inc. (UHS - Free Report) is set to report second-quarter 2020 results on Jul 27, after market close.
For the to-be-reported quarter, the Zacks Consensus Estimate for earnings is pegged at 53 cents per share, indicating an 80.8% plunge from the year-ago reported figure.
Let’s see how things are shaping up for this announcement.
In the quarter to be reported, the company’s performance is likely to have been dented by lower admissions. The volume of non-COVID patients is expected to have declined in the period.
The company’s segments, namely Acute Care and Behavioral Health, which have been contributing to the top line over the last several quarters, might affect results due to the coronavirus pandemic.
The consensus mark for net revenues at Acute Care and Behavioral Health suggests a respective 16.9% and 9.8% fall from the prior-year reported numbers.
The company is likely to have witnessed lower emergency room visits and elective or scheduled procedures due to government-imposed restrictions.
The Zacks Consensus Estimate for total revenues stands at $2.3 billion, implying a 16.5% deterioration from the year-earlier reported figure.
The consensus estimate for average licensed beds at Behavorial Health segment suggests a 0.7% dip while the same for acute care (U.S. and Puerto Rico) indicates an increase of 1.3%.
At Behavorial Health Centers, the consensus mark for patient days hints at a slip of 0.9% due to contracting patient volumes. While the estimate for patient days for acute care (U.S. and Puerto Rico) indicates a 5.3% drop year over year.
Also, the company is expected to have incurred escalating expenses due to higher salaries, wages and benefits plus other operating expenses, which in turn, might have weighed on its margins.
What the Quantitative Model States
Our proven model predicts an earnings beat for Universal Health this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: Universal Health has an Earnings ESP of +29.21%. This is because the Most Accurate Estimate is pegged at 69 cents per share, higher than the Zacks Consensus Estimate of 53 cents. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Universal Health Services, Inc. Price and EPS Surprise
Universal Health Services, Inc. price-eps-surprise | Universal Health Services, Inc. Quote
Zacks Rank: Universal Health carries a Zacks Rank #3, which increases the predictive power of ESP.
Q1 Highlights and Surprise History
Universal Health’s first-quarter 2020 adjusted earnings of $1.73 per share missed the Zacks Consensus Estimate by 33.2%. Moreover, the bottom line deteriorated 29.4% year over year.
Results were impacted by a pre-tax unrealized loss of $4.3 million due to lower market value of shares of certain securities.
The company’s earnings managed to beat estimates in two of the trailing four quarters and missed the same in the remaining two. The average trailing four-quarter surprise is a negative 6.9%.
Stocks to Consider
Some stocks worth considering from the medical sector with the perfect mix of elements to surpass estimates in the next releases are as follows:
Centene Corporation (CNC - Free Report) has an Earnings ESP of +0.88% and a Zacks Rank of 3, currently. The company is scheduled to release second-quarter earnings on Jul 28.
Anthem, Inc. is slated to announce second-quarter earnings on Jul 29. The stock has an Earnings ESP of +3.73% and a Zacks Rank #2 at present.
Molina Healthcare, Inc. (MOH - Free Report) is set to report second-quarter earnings on Jul 30. The stock is currently a #2 Ranked player and has an Earnings ESP of +4.08%.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>